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==========================

Early recognition and timely management of pediatric sepsis is challenging for the pediatric intensivist.\[[@ref1][@ref2][@ref3]\] Sepsis remains the leading cause of mortality in children admitted in the Pediatric Intensive Care Units (PICUs) in Pakistan as well as around the world.\[[@ref4][@ref5][@ref6][@ref7]\] Delay in the diagnosis and management results in rapid progression to circulatory collapse, multiple organ dysfunction syndrome (MODS), and eventually death.\[[@ref8][@ref9]\] Continuing high rates of morbidity and mortality in PICU due to infections dictate the need for biomarkers to determine the prognosis of critically ill children at admission.\[[@ref3][@ref10]\]

Conventionally, diagnosis of sepsis was based on clinical signs and symptoms of sepsis, such as fever, tachycardia, and tachypnea, supported by cultures. More recently, sepsis biomarkers have been used. Currently, most commonly used biomarkers to identify sepsis and predict outcome are lactic acid and C-reactive protein (CRP).\[[@ref11]\] Lactic acid levels have been used as a biomarker for tissue hypoxia and anaerobic metabolism, and it is the most widely utilized sepsis biomarker indicating organ dysfunction.\[[@ref12]\] Investigators have reported that persistent hyperlactatemia serves as the predictor of poor outcome in critically ill children suffering from sepsis.\[[@ref13]\] However, factors associated with sepsis such as liver failure or mitochondrial dysfunction may also cause false elevation of lactic acid. CRP is a marker of acute inflammatory response rather than of infection and is nonspecific. However, it may be useful in determining sepsis severity and its progression.\[[@ref14]\] CRP has also been shown to have a poor predictor of mortality compared to other biomarkers in pediatric population.\[[@ref15]\] Another promising marker in clinical use since the last decade is serum procalcitonin (PCT). PCT is a peptide precursor of the hormone calcitonin.\[[@ref16]\] The level of PCT rises in a response to a proinflammatory stimulus, especially of bacterial origin.\[[@ref17][@ref18]\] In addition to its release during bacterial infection, PCT is also closely related to the severity of systemic inflammation and has a reliable kinetics of induction and elimination.\[[@ref19]\] It can, therefore, be used to monitor the course of systemic inflammation and guide the physician in therapeutic decision-making.\[[@ref20][@ref21]\] Few studies have addressed serum PCT levels in relation to hospital mortality, and we wish to evaluate this association of increased PCT with morbidity and mortality in children admitted in the ICUs.\[[@ref22][@ref23]\] Biomarkers to diagnose sepsis may facilitate early recognition and intervention. Serum biomarkers to determine the prognosis of critically ill children at admission to the PICU or during the stay in PICU constitute a clinical necessity. As the clinical course and pathophysiology of sepsis is also influenced by patient age, it is expected that diagnostic accuracy of certain biomarkers are age specific and may show differences when considering neonates and children as compared to adult patients. We conducted this study to evaluate the association and the prognostic value of PCT, CRP, and lactic acid in children admitted to the PICU of our hospital to test the hypothesis that higher plasma concentrations would be associated with increased prediction of morbidity and mortality risk in critically ill children.

M[ATERIALS AND]{.smallcaps} M[ETHODS]{.smallcaps} {#sec1-2}
=================================================

Study design and setting {#sec2-1}
------------------------

This observational study was conducted on patients in the PICU of our hospital. Medical records of children (1 month--16 years) tested for serum PCT at the time of admission in PICU from July 1, 2013, to January 15, 2015, were reviewed. Exemption from the institute\'s ethical review committee (ERC) was sought (ERC identification number: 3453-Pat-ERC-15), and anonymity of the participants was maintained by coding the medical record numbers with study identifications.

Data collection {#sec2-2}
---------------

Medical charts of the participants were reviewed to note their demographics, primary diagnosis, comorbidities, length of stay in PICU, and outcome (survived or expired) at the time of discharge from hospital. In addition, the Pediatric Risk of Mortality (PRISM III-24) Score was assessed during the first 24 h of care in PICU \[[Figure 1](#F1){ref-type="fig"}\]. Laboratory parameters noted were blood cultures, white blood cell counts, neutrophil counts, serum CRP, plasma lactic acid, and serum PCT, all analyzed on day 1 of PICU admission. The initial PCT result in all patients was on the day of PICU admission. MODSs were defined as per the International Pediatric Sepsis Consensus Conference.\[[@ref24]\]

![Methodology of patient recruitment and data collection. It is the flow diagram of patients' enrollment and details of data collection of the current study. PCT: Procalcitonin; CRP: C-reactive protein; WBC: White blood cell count](IJCCM-22-91-g001){#F1}

Procalcitonin, C-reactive protein, and lactic acid assays {#sec2-3}
---------------------------------------------------------

All samples were analyzed in the Section of Chemical Pathology, Department of Pathology and Laboratory Medicine, Aga Khan University Hospital, Stadium Road, Karachi, Pakistan. The PCT analysis was performed by Elecsys BRAHMS PCT electrochemiluminescence immunoassay on Cobas E-170 by Roche Diagnostics, Germany. For quality control, two levels of BRAHMS PreciControl were used with each batch of analysis. Lower detection limit of the assay was 0.02 ng/ml and upper detection limit was 100 ng/ml. Results were determined via a calibrator curve which was instrument specific generated by 2-point calibration and a master curve provided via the reagent barcode. The analyzer automatically calculated the PCT concentration of each sample. Plasma lactic acid was measured by photometric lactate oxidase enzymatic method on ADVIA 1800 chemistry system, by Siemens. Values of lactic acid were expressed in mmol/L. Serum CRP was measured by latex-enhanced immunoturbidimetric method on ADVIA 1800 chemistry system, by Siemens. For quality control, three levels of internal quality control materials were used with each batch of analysis. During the study period, the College of American Pathologists proficiency testing survey for PCT, CRP, and lactic acid was also run and was acceptable.

Statistical analysis {#sec2-4}
--------------------

The data were analyzed using Statistical Package for the Social Sciences version 19 (Armonk, NY: IBM Corp). The continuous variables with normal distribution were expressed as means ± 2 standard deviation and were compared using the Student\'s *t*-test, whereas continuous variables with an asymmetric distribution were expressed as median and the respective interquartile range (IQR) and were compared using the nonparametric Mann--Whitney U-test, for independent samples. Patient outcome was assessed at the time of discharge from hospital, and the patients were divided into nonsurvivor and survivor groups. Between-group differences were tested using the Chi-square test for categorical data and Mann--Whitney\'s U-test for continuous. *P* \<0.05 was considered statistically significant and *P* \< 0.001 as highly significant.

R[ESULTS]{.smallcaps} {#sec1-3}
=====================

A total of 167 children admitted to the PICU were enrolled. The median age of the study population was 3 years (0--16 years), with 58.6% being males. Patients' characteristics are summarized in [Table 1](#T1){ref-type="table"}. In 26.9% of patients, the primary diagnosis was cardiovascular disease, while 19.7% had pneumonia or bronchiolitis, 11.3% suffered from sepsis or septic shock, 10.1% from central nervous system (CNS) infections and 10.1% had CNS disease, 5.3% had gastrointestinal disorders, 0.6% kidney disease and 15.5% suffered from miscellaneous causes. Out of the total, 76.8% were admitted through emergency, 19.9% from wards, and 3.3% from operation rooms. All 167 patients had blood culture within 48 h of admission and were reported positive in 34 patients (20%). The overall median PRISM score was 4 (IQR 10--0) while the median PCT, lactic acid, and CRP are summarized in [Table 1](#T1){ref-type="table"}. PCT level \>2 ng/ml was observed in 113 (67.6%) patients.

###### 

Characteristics of the study group (*n*=167)

![](IJCCM-22-91-g002)

The median PICU length of stay was 3 days (range 1--18 days). In total, 167 patients who were admitted to the PICU during the study period were divided into two groups according to the outcome: nonsurvivor group (*n* = 54) and survivor group (*n* = 113). On discharge, 66.7% of the children survived. [Table 2](#T2){ref-type="table"} summarizes the descriptive comparison between the two groups.

###### 

Comparison of baseline characteristics and physiological and laboratory parameters on Intensive Care Unit admission between survivors and nonsurvivors (*n*=157)

![](IJCCM-22-91-g003)

No significant differences were found for age, and the proportion of males was higher in the nonsurvivor group. Nonsurvivors had higher lactic acid (*P* \< 0.05) and greater incidence of MODS (*P* \< 0.05) than the survivors. Among the biomarkers, only plasma levels of lactic acid were significantly higher in nonsurvivors compared to that of survivors (4.7 \[7.6-2.07\] vs. 2.0 \[3.0-1.3\] ng/ml; *P* \< 0.001) \[[Figure 2](#F2){ref-type="fig"}\]. To determine variables associated with mortality, binary logistic regression analysis was done and only lactic acid was associated with mortality (*P* \< 0.05).

![Comparison of lactic acid (in mmol/L) between survivors and nonsurvivors. Data are presented as box plots with median lines, 25- and 75-percentile boxes, and 10- and 90-percentile error bars. The circles represent the outliers](IJCCM-22-91-g004){#F2}

We identified a higher PRISM Score of \> 10 upon admission to the PICU as a prognostic marker for hospital survival in critically ill patients (hazard ratio 4.623, 95% confidence interval \[CI\] 1.86--11.45; *P* = 0.02). As shown in [Table 3](#T3){ref-type="table"}, the onset of MODS was higher in patients with greater CRP and lactic acid concentrations. Among the nonsurvivors, majority (94.4%) had MODS (median PCT: 7.9, CI: 1--51.8; *P* \< 0.01), whereas in the survivors, 38.05% had onset of MODS (median PCT: 6.2, CI: 58.8--1.2; *P* \< 0.01).

###### 

Comparison of median C-reactive protein, procalcitonin, and lactic acid in according to the presence or absence of multiple organ dysfunctions
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D[ISCUSSION]{.smallcaps} {#sec1-4}
========================

Sepsis remains a major cause of morbidity and mortality in children. The use of predictive and prognostic biomarkers has the potential to improve early recognition and timely intervention of patients with sepsis leading to improved outcomes. Assessment in this study revealed that lactic acid has a better discriminative ability than PCT or CRP in predicting mortality in critically ill patients admitted to PICU.

Serum PCT, CRP, and lactic acid levels rise in response to infection and high levels have been found to correlate with the severity of infection, development of MODS, and worse outcome in various studies, but data from PICU are scarce and variable.\[[@ref25][@ref26][@ref27]\] Most earlier studies on the potential utility of PCT in the setting of sepsis have focused on its diagnostic value, rather than prognostic value.\[[@ref28]\] Studies evaluating the prognostic utility of PCT show conflicting results. Dahaba *et al*. also reported no association of PCT levels and mortality in their postoperative critically ill patients.\[[@ref29]\] Han *et al*. showed that increasing PCT levels were associated with persistent bacterial infections and development of MODS, but their study did not show the prognostic value of PCT.\[[@ref19]\] On the other hand, Meng *et al*. in their study from adult ICU showed that serum PCT levels \>10 ng/ml at the time of admission were associated with all-cause short-term mortality (*P* \< 0.05).\[[@ref30]\] A prospective study on 81 pediatric patients with suspected sepsis showed that high PCT level was a good predictor of mortality.\[[@ref31]\] Similarly, Magrini *et al*. showed that PCT level variations in their patients with local and generalized infections were highly predictive of in-hospital mortality.\[[@ref32]\] Only plasma lactic acid which is a marker for tissue hypoxia in our study was found to be significantly associated with mortality as compared to PCT. Our study shows that high CRP and lactic acid and not serum PCT levels were associated with the development of MODS. This could be due to poor tissue perfusion and MODS in critically ill children. Casado-Flores *et al*. showed that PCT levels \>10 ng/ml were associated with MODS in children with meningococcal infections.\[[@ref33]\] Preliminary results in an observational study in children, younger than 19 years of age (*n* = 239), with sepsis also showed high lactic acid levels at initial presentation to be associated with progression to organ dysfunction and critical illness.\[[@ref34]\]

Several limitations of this study merit consideration. This is a single-center, observational study with limited sample size. Patient inclusion was based on medical charts, and only children with suspicion of infections whose PCT levels were measured were included in the study. Therefore, selection bias cannot be ruled out. Our results need to be validated on prospective larger patient population. Finally, we have performed an observational study that does not allow drawing any conclusion concerning therapeutic interventions.

C[ONCLUSIONS]{.smallcaps} {#sec1-5}
=========================

In the present study, lactic acid appeared to be a more accurate prognostic biomarker associated with the development of all-cause MODS and worse outcome in critically ill children admitted in PICU. Our study findings in PICU patients suggest that the prognostic value of plasma lactic acid is likely to be greater in the critically ill, but prospective studies are required to address the true added value of plasma lactic acid in PICU and its cost implications. Similar studies on pediatric population from critical care areas are scarce and additional investigations are required to validate these findings more definitively.
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